U. Baber, J. Chandrasekhar, and S. Sartori, Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention, JACC: Cardiovascular Interventions, vol.10, issue.20, pp.2017-2042, 2017.
DOI : 10.1016/j.jcin.2017.02.047

S. James, A. Budaj, and P. Aylward, Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function: Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial, Circulation, vol.122, issue.11, pp.1056-67, 2010.
DOI : 10.1161/CIRCULATIONAHA.109.933796

URL : http://circ.ahajournals.org/content/circulationaha/122/11/1056.full.pdf

O. Morel, E. Ghannudi, S. Jesel, and L. , Cardiovascular Mortality in Chronic Kidney Disease Patients Undergoing Percutaneous Coronary Intervention Is Mainly Related to Impaired P2Y12 Inhibition by Clopidogrel, Journal of the American College of Cardiology, vol.57, issue.4, pp.399-408, 2011.
DOI : 10.1016/j.jacc.2010.09.032

URL : https://doi.org/10.1016/j.jacc.2010.09.032

K. Jeong, J. Cho, and J. Woo, Platelet reactivity after receiving clopi-dogrel compared with ticagrelor in patients with kidney failure treated with hemodialysis: a randomized crossover study
DOI : 10.1053/j.ajkd.2014.11.023